| Dr Charles F Francke Iii, MD | |
|
8135 New Lagrange Rd, Louisville, KY 40222-4682 | |
| (502) 423-1997 | |
| (502) 423-1935 |
| Full Name | Dr Charles F Francke Iii |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 8135 New Lagrange Rd, Louisville, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053535278 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 23384 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles F Francke Iii, MD 8901 Lyndon Lakes Pl, Louisville, KY 40242-4537 Ph: (502) 426-3458 | Dr Charles F Francke Iii, MD 8135 New Lagrange Rd, Louisville, KY 40222-4682 Ph: (502) 423-1997 |
News Archive
A study has found functional and inflammatory changes in the nasal and lower airways of young, healthy smokers in the absence of pulmonary function decline.
BNY Mellon, the global leader in asset management and securities servicing, has been appointed by Takeda Pharmaceutical Company Limited (Takeda) as the depositary bank for its sponsored American depositary receipt (ADR) program. Each Takeda ADR represents one-half of a common share and trades on the over-the-counter (OTC) market under the symbol TKPYY. Takeda's common shares trade on the Tokyo Stock Exchange as well as four other exchanges in Japan under the code "4502." Previously, Takeda traded as an unsponsored ADR program serviced by multiple depositaries.
Stroke patients were nearly 50% more likely than heart attack patients to develop depression, and female stroke patients had a higher risk of depression than their male counterparts, according to two preliminary studies by the same research group to be presented at the American Stroke Association's International Stroke Conference 2021.
A study assessing how people with immune system deficiencies or dysregulations respond to COVID-19 vaccination has begun enrolling participants at the National Institutes of Health Clinical Center in Bethesda, Maryland.
Data from the first phase III clinical trial of NovoCure's NovoTTF device for treatment of patients with recurrent glioblastoma (GBM) were presented today as a late breaking abstract during the Neuro-Oncology session at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Study results show that NovoTTF, a novel, non-invasive, portable medical device, may be as or more effective than the best available chemotherapies for GBM, but without the toxicity usually associated with cytotoxic or targeted treatments.
› Verified 5 days ago
Dr. Christopher R. Shafer, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 401 E Chestnut St, Suite 510, Louisville, KY 40202 Phone: 502-588-4800 Fax: 502-588-4801 | |
David James Haustein, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 220 Abraham Flexner Way # 1200, Louisville, KY 40202 Phone: 502-584-3377 | |
Elizabeth B. Shelton, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4010 Dupont Cir, Ste 312, Louisville, KY 40207 Phone: 812-282-1888 Fax: 812-285-8392 | |
Manoocher Mofidi, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2225 W Broadway, Louisville, KY 40211 Phone: 502-589-8600 Fax: 502-589-8771 | |
Dr. Steven B Lippmann, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 550 S Jackson St, Louisville, KY 40202 Phone: 502-852-1759 Fax: 502-852-5098 | |
Tanya Wozniak, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4201 Springhurst Blvd Ste 203, Louisville, KY 40241 Phone: 502-425-6690 Fax: 502-890-2092 | |
Dr. Gary Fox, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3906 S Dupont Sq, Louisville, KY 40207 Phone: 502-895-8218 Fax: 502-895-8219 |